Hydrocephalus Market Report 2026

Hydrocephalus Market Overview

• Hydrocephalus market size has reached to $3.66 billion in 2025 • Expected to grow to $4.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Healthcare Infrastructure Expansion Propels Hydrocephalus Market Growth • Market Trend: Innovation In Hydrocephalus Treatment With Eshunt System • North America was the largest region in 2025.

What Is Covered Under Hydrocephalus Market?

Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) that commonly passes through the spaces of the brain and spinal column in normal circumstances starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. The main types of hydrocephalus are congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, ex-vacuo hydrocephalus. Congenital hydrocephalus is caused by a birth abnormality or brain malformation that causes excessive cerebrospinal fluid (CSF) to build in the subarachnoid space of the brain. Hydrocephalus can be in pediatric or adult and can be detected using MRI, CT scan, head ultrasound, others. There are various end users of hydrocephalus such as hospitals, diagnostic centers, academic institutions, research organizations.

What Is The Hydrocephalus Market Growth Forecast?

The hydrocephalus market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing investments in neurological research, rising demand for early diagnosis solutions, expansion of advanced imaging technologies, growing focus on minimally invasive treatments, increased funding for neurological healthcare. Major trends in the forecast period include increasing use of advanced neuroimaging techniques, rising adoption of early diagnostic screening, growing focus on pediatric hydrocephalus management, expansion of clinical research in neurological disorders, enhanced integration of data-driven diagnostics.

Global Hydrocephalus Market Segmentation

1) By Type: Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus 2) By Age Group: Pediatric, Adult 3) By Diagnostics: MRI, CT Scan, Head Ultrasound, Other Diagnostics 4) By End User: Hospitals, Diagnostic Centers, Academic Institutions, Research Organizations Subsegments: 1) By Congenital Hydrocephalus: Associated With Genetic Disorders, Associated With Neural Tube Defects 2) By Acquired Hydrocephalus: Post-Traumatic Hydrocephalus, Hydrocephalus Due To Tumors, Hydrocephalus Following Infection 3) By Normal-Pressure Hydrocephalus (NPH): Idiopathic Normal-Pressure Hydrocephalus, Secondary Normal-Pressure Hydrocephalus

What Is The Driver Of The Hydrocephalus Market?

The rapid expansion of healthcare infrastructure is expected to propel the growth of the hydrocephalus market in the coming years. The term healthcare infrastructure refers to the system of buildings, organizations, and resources committed to promoting, restoring, and sustaining health and consists of several different components that work together to offer healthcare to individuals and communities. To provide patients with hydrocephalus with comprehensive and specialized treatment, a developed healthcare infrastructure is necessary. It ensures quick diagnosis, adequate therapy, and continued care, all of which contribute to improved outcomes for people suffering from this ailment. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from 6,093 hospitals in 2022. Therefore, the rapid expansion of healthcare infrastructure is driving the hydrocephalus industry.

Key Players In The Global Hydrocephalus Market

Major companies operating in the hydrocephalus market are Johnson & Johnson Corporation, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Texas Children's Hospital, Boston Children’s Hospital, Karl Storz SE and Co. KG, Integra LifeSciences Corporation, Children's National Hospital, Natus Medical Incorporated, Aesculap Inc., Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Moller Medical GmbH, Spiegelberg GmbH & Co. KG, Delta Surgical Limited, Kaneka Medix Corporation, Tokibo Co. Ltd.

Global Hydrocephalus Market Trends and Insights

Major companies operating in the hydrocephalus market are innovating advanced products, such as endovascularly implantable cerebrospinal fluid (CSF) shunts, to improve the management of hydrocephalus by providing minimally invasive solutions to regulate CSF flow and relieve intracranial pressure. An endovascularly implantable cerebrospinal fluid (CSF) shunt is a type of shunt system that is placed within blood vessels (endovascularly) to manage hydrocephalus, a condition characterized by an excess buildup of CSF in the brain. For instance, in August 2024, CereVasc Inc., a US-based clinical-stage medical device company, received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health of the eShunt System. The eShunt System is a medical device designed for treating Normal Pressure Hydrocephalus (NPH). The system includes an endovascularly implantable cerebrospinal fluid (CSF) shunt that aims to bypass the need for invasive surgery and general anesthesia. The implantation of the eShunt will be performed under local anesthesia using a minimally invasive femoral venous approach, conducted in an angiography suite, which is a specialized medical facility.

What Are Latest Mergers And Acquisitions In The Hydrocephalus Market?

In June 2023, CereVasc, Inc., a US-based clinical-stage medical device company that works on treatment for communicating hydrocephalus, announced a corporate partnership with LianMedical to expand hydrocephalus treatment in Asia. Through this collaboration, the companies aim to address unmet needs in hydrocephalus care in Asia, bringing minimally invasive treatment for communicating hydrocephalus to a broader patient population. LianMedical is a China-based medical device company.

Regional Outlook

North America was the largest region in the hydrocephalus market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hydrocephalus Market?

The hydrocephalus market consists of sales of shunts, valves, and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.